Complete nucleotide sequence of a small qnrS1 - Carrying plasmid from Salmonella enterica subsp. enterica Typhimurium DT193 [1]

Corinna Kehrenberg; Katie I. Hopkins; John Threlfall; Stefan Schwarz

doi:10.1093/jac/dkm283

Complete nucleotide sequence of a small qnrS1 - Carrying plasmid from Salmonella enterica subsp. enterica Typhimurium DT193 [1]

Corinna Kehrenberg, Katie I. Hopkins, John Threlfall, Stefan Schwarz

Research output: Contribution to journal › Letter › peer-review

41 Citations (Scopus)

Original language	English
Pages (from-to)	903-905
Number of pages	3
Journal	Journal of Antimicrobial Chemotherapy
Volume	60
Issue number	4
DOIs	https://doi.org/10.1093/jac/dkm283
Publication status	Published - Oct 2007

Bibliographical note

Funding Information:
T. M. F. has received recent research funding from Abbott, Arpida AG, AstraZeneca, Bristol–Myers Squibb, Bayer, Binax Incorporated, Cubist, Genzyme, GlaxoSmithKline, Ortho-McNeil, Oscient, Pfizer, Sanofi-Aventis and Wyeth, is a consultant to Sanofi-Aventis, Bayer, GlaxoSmithKline, Ortho-McNeil, Merck, Oscient, Pfizer and Wyeth and is on the Speakers’ Bureau of Abbott, Sanofi-Aventis, GlaxoSmithKline, Merck, Ortho-McNeil, Oscient, Pfizer, Schering Plough and Wyeth. Further, he does not own stocks in any company that might be financially affected by the conclusions of this article. L. A. M. has received research funding from Bayer, Pfizer, Sanofi-Aventis and Wyeth, is a consultant to AstraZeneca, Aventis, Bayer, Pfizer, Sanofi-Aventis and Wyeth and is on the Speakers’ Bureau of Aventis, Bayer, Oscient, Pfizer and Sanofi-Aventis. G. S. T. was an employee of Oscient Pharmaceuticals at the time of the study and is currently an employee of Replidyne Pharmaceuticals, Louisville, CO, USA.

Funding Information:
This study was financially supported by internal funding provided by the Institut für Tierzucht (FAL).

Keywords

Enteric pathogens
Mobilization
Quinolone resistance
Recombination

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/jac/dkm283

Cite this

@article{dac906aa09e643d0931fe038a4a361df,

title = "Complete nucleotide sequence of a small qnrS1 - Carrying plasmid from Salmonella enterica subsp. enterica Typhimurium DT193 [1]",

keywords = "Enteric pathogens, Mobilization, Quinolone resistance, Recombination",

author = "Corinna Kehrenberg and Hopkins, {Katie I.} and John Threlfall and Stefan Schwarz",

note = "Funding Information: T. M. F. has received recent research funding from Abbott, Arpida AG, AstraZeneca, Bristol–Myers Squibb, Bayer, Binax Incorporated, Cubist, Genzyme, GlaxoSmithKline, Ortho-McNeil, Oscient, Pfizer, Sanofi-Aventis and Wyeth, is a consultant to Sanofi-Aventis, Bayer, GlaxoSmithKline, Ortho-McNeil, Merck, Oscient, Pfizer and Wyeth and is on the Speakers{\textquoteright} Bureau of Abbott, Sanofi-Aventis, GlaxoSmithKline, Merck, Ortho-McNeil, Oscient, Pfizer, Schering Plough and Wyeth. Further, he does not own stocks in any company that might be financially affected by the conclusions of this article. L. A. M. has received research funding from Bayer, Pfizer, Sanofi-Aventis and Wyeth, is a consultant to AstraZeneca, Aventis, Bayer, Pfizer, Sanofi-Aventis and Wyeth and is on the Speakers{\textquoteright} Bureau of Aventis, Bayer, Oscient, Pfizer and Sanofi-Aventis. G. S. T. was an employee of Oscient Pharmaceuticals at the time of the study and is currently an employee of Replidyne Pharmaceuticals, Louisville, CO, USA. Funding Information: This study was financially supported by internal funding provided by the Institut f{\"u}r Tierzucht (FAL).",

year = "2007",

month = oct,

doi = "10.1093/jac/dkm283",

language = "English",

volume = "60",

pages = "903--905",

journal = "Journal of Antimicrobial Chemotherapy",

issn = "0305-7453",

publisher = "Oxford University Press",

number = "4",

}

TY - JOUR

T1 - Complete nucleotide sequence of a small qnrS1 - Carrying plasmid from Salmonella enterica subsp. enterica Typhimurium DT193 [1]

AU - Kehrenberg, Corinna

AU - Hopkins, Katie I.

AU - Threlfall, John

AU - Schwarz, Stefan

N1 - Funding Information: T. M. F. has received recent research funding from Abbott, Arpida AG, AstraZeneca, Bristol–Myers Squibb, Bayer, Binax Incorporated, Cubist, Genzyme, GlaxoSmithKline, Ortho-McNeil, Oscient, Pfizer, Sanofi-Aventis and Wyeth, is a consultant to Sanofi-Aventis, Bayer, GlaxoSmithKline, Ortho-McNeil, Merck, Oscient, Pfizer and Wyeth and is on the Speakers’ Bureau of Abbott, Sanofi-Aventis, GlaxoSmithKline, Merck, Ortho-McNeil, Oscient, Pfizer, Schering Plough and Wyeth. Further, he does not own stocks in any company that might be financially affected by the conclusions of this article. L. A. M. has received research funding from Bayer, Pfizer, Sanofi-Aventis and Wyeth, is a consultant to AstraZeneca, Aventis, Bayer, Pfizer, Sanofi-Aventis and Wyeth and is on the Speakers’ Bureau of Aventis, Bayer, Oscient, Pfizer and Sanofi-Aventis. G. S. T. was an employee of Oscient Pharmaceuticals at the time of the study and is currently an employee of Replidyne Pharmaceuticals, Louisville, CO, USA. Funding Information: This study was financially supported by internal funding provided by the Institut für Tierzucht (FAL).

PY - 2007/10

Y1 - 2007/10

KW - Enteric pathogens

KW - Mobilization

KW - Quinolone resistance

KW - Recombination

UR - http://www.scopus.com/inward/record.url?scp=34548717567&partnerID=8YFLogxK

U2 - 10.1093/jac/dkm283

DO - 10.1093/jac/dkm283

M3 - Letter

C2 - 17652106

AN - SCOPUS:34548717567

SN - 0305-7453

VL - 60

SP - 903

EP - 905

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

IS - 4

ER -

Complete nucleotide sequence of a small qnrS1 - Carrying plasmid from Salmonella enterica subsp. enterica Typhimurium DT193 [1]

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Cite this